Iverlim Cream contains Ivermectin 1% w/w, a potent topical antiparasitic formulation used to treat skin infestations such as scabies, lice, and other ectoparasitic infections. Ivermectin works by interfering with the nervous system of parasites, causing paralysis and eventual elimination, providing fast and effective relief.
This cream falls under the dermatology and antiparasitic segment, offering both clinicians and patients a convenient topical option that reduces the risk of systemic side effects compared to oral therapy. Its 1% w/w concentration ensures high efficacy with minimal irritation for sensitive skin areas.
Iverlim Cream is in high demand among dermatologists, hospitals, clinics, and PCD pharma networks, owing to its effectiveness, ease of application, and trusted clinical profile. It is suitable for both adult and pediatric use under medical supervision.
For PCD pharma franchise and B2B partners, Iverlim Cream represents a high-margin, high-demand opportunity. Its well-recognized efficacy, safe profile, and broad applicability in parasitic skin infections make it an essential addition to dermatology portfolios. This ensures strong business growth and reliable market demand in domestic and export markets.